TSW
PCRX icon

Three Seasons Wealth’s Pacira BioSciences PCRX Stock Holding History

Three Seasons Wealth’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
62,942
+19,107
+44% +$452K 0.15% 56
2026
Q1 		$991K Buy
43,835
+20,504
+88% +$456K 0.38% 67
2025
Q4 		$604K Buy
+23,331
New +$555K 0.06% 91

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Three Seasons Wealth's PCRX Position: Q2 2026 in Review

Three Seasons Wealth increased its Pacira BioSciences (PCRX) stake by 44% in Q2 2026, buying an estimated $452K and bringing the position to 62,942 shares worth $1.6M. The position accounts for 0.15% of the portfolio, ranked #56.

Three Seasons Wealth first reported a position in PCRX in Q4 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Three Seasons Wealth held 62,942 shares of Pacira BioSciences worth $1.6M as of Q2 2026.
  • Three Seasons Wealth bought 19,107 Pacira BioSciences shares in Q2 2026, an estimated $452K.
  • Pacira BioSciences made up 0.15% of Three Seasons Wealth's portfolio in Q2 2026, its #56 holding.
  • Three Seasons Wealth first reported a position in Pacira BioSciences in Q4 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Three Seasons Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.